My bookmarksSign up free
Source

2009/752/EC: Commission Decision of 12 October 2009 authorising the placing on the market of a lipid extract from Antarctic Krill Euphausia superba as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7647)

2009/752/EC: Commission Decision of 12 October 2009 authorising the placing on the market of a lipid extract from Antarctic Krill Euphausia superba as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7647)

Regulation (EC) No 258/97 · Decision · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Lipid extract from Antarctic Krill Euphausia superba as specified in Annex I, may be placed on the market in the Community as a novel food ingredient for the uses and at the maximum levels as listed in Annex II.

Article 2

Open ↗

The designation ‘lipid extract from the crustacean Antarctic Krill Euphausia superba ’ shall be displayed on the labelling of the product as such or in the list of ingredients of foodstuffs containing it.

Article 3

Open ↗

This Decision is addressed to Neptune Technologies & Bioressources Inc., 225 Promenade du Centropolis, Suite 200, Laval, Quebec H7T 0B3, Canada.

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I SPECIFICATION OF LIPID EXTRACT FROM ANTARCTIC KRILL EUPHAUSIA SUPERBA Description To produce lipid extract from Antarctic Krill Euphausia superba deep-frozen Antarctic krill is crushed and subjected to an extraction with acetone. Proteins and krill material are removed from the lipid extract by filtration. The acetone and residual water are removed by evaporation. Test Specification Saponification value Not more than 185 mg KOH/g Peroxide value (PV) Not more than 0,2 meq O 2 /kg oil Moisture and volatiles Not more than 0,9 % Phospholipids Not more than 50 % Trans-fatty acids Not more than 1 % EPA (eicosapentaenoic acid) Not less than 15 % DHA (docosahexaenoic acid) Not less than 7 %

ANNEX IISupplementary provisions

Open ↗

ANNEX II USES OF LIPID EXTRACT FROM ANTARCTIC KRILL EUPHAUSIA SUPERBA Use group Maximum content of combined DHA and EPA Dairy products except milk-based drinks 200 mg/100 g or for cheese products 600 mg/100 g Dairy analogues except drinks 200 mg/100 g or for analogues to cheese products 600 mg/100 g Spreadable fat and dressings 600 mg/100 g Breakfast cereals 500 mg/100 g Food supplements 200 mg per daily dose as recommended by the manufacturer Dietary foods for special medical purposes In accordance with the particular nutritional requirements of the persons for whom the products are intended Foods intended for use in energy restricted diets for weight reduction 200 mg/meal replacement

Other acts of the same type
Council Decision (EU) 2025/633 of 24 March 2025 on the conclusion of the Agreement between the European Union and the People’s Republic of Bangladesh on certain aspects of air servicesCouncil Decision (EU) 2025/642 of 24 March 2025 amending Decision 98/481/EC approving the external auditors of the European Central BankCouncil Decision (EU) 2025/643 of 24 March 2025 on the conclusion, on behalf of the European Union, of the Protocol (2024-2029) implementing the Fisheries Partnership Agreement between the European Community and the Republic of Cabo VerdeCouncil Implementing Decision (EU) 2025/644 of 24 March 2025 authorising France to apply a reduced rate of taxation to unleaded petrol used as motor fuel and consumed in Corsican departments in accordance with Directive 2003/96/ECDecision (EU) 2025/673 of the European Central Bank of 24 March 2025 amending Decision (EU) 2023/1681 on the provision to the European Central Bank of supervisory data reported to the national competent authorities by the supervised entities (ECB/2023/18) (ECB/2025/10)Commission Decision (EU) 2025/1235 of 24 March 2025 on the measure State aid SA.54155 (2021/NN) implemented by Spain – Arbitration award to Antin (notified under document C(2025) 1781)Commission Implementing Decision (EU) 2025/526 of 21 March 2025 designating a Union testing facility for electromagnetic compatibility in accordance with Regulation (EU) 2019/1020 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2025/540 of 19 March 2025 amending the Annex to Implementing Decision (EU) 2023/2447 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States (notified under document C(2025) 1818)Commission Decision (EU) 2025/543 of 19 March 2025 on the compliance of the revised unit rates for air navigation charges set by Italy for year 2024 (notified under document C(2025) 1624)Commission Implementing Decision (EU) 2025/503 of 18 March 2025 laying down rules for the application of Regulation (EU) 2024/1351 of the European Parliament and of the Council, as regards the template to be used by Member States to ensure that their national asylum and migration management strategies are comparable on specific core elementsCouncil Implementing Decision (EU) 2025/539 of 18 March 2025 authorising Estonia to apply a special measure derogating from Article 26(1), point (a), and Articles 168 and 168a of Directive 2006/112/EC on the common system of value added taxCouncil Decision (EU) 2025/542 of 18 March 2025 establishing the position to be taken on behalf of the European Union regarding the decision of the Participants to the Sector Understanding on Export Credits for Civil Aircraft contained in Annex III to the Arrangement on Officially Supported Export Credits on amendments to that Sector Understanding

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next